Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
JAMA Network Open|February 9, 2019
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate CancerAmar U Kishan, Audrey Dang, Alan J Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II StudyAmar U Kishan, Luca F Valle, Holly Wilhalme, et al.
European Urology|September 18, 2024
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate CancerAdam B Weiner, Raag Agrawal, Nicholas K Wang, et al.
European Urology|May 29, 2020
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate CancerAmar U Kishan, Tahmineh Romero, Mohammed Alshalalfa, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.
Pageof 13